Regina W. Wang - Concepedia

Author

Regina W. Wang

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

R W Wang, R. Wang, REGINA W. WANG, Regina W. Wang

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Merck (Japan)Rutgers, The State University of New Jersey University of Washington Merck Canada Inc. (Canada)

About

Regina W. Wang is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biochemistry, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	10	11	761
2	Medicine	9	9	739
3	Natural Sciences	9	9	617
4	Health Sciences	2	2	171
5	Chemical Biology	1	1	141

Regina W. Wang

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America Scott Grimm, Heidi J. Einolf, Steven D. Hall, Drug Metabolism and Disposition	2009	304
Human Cytochrome P-450 3A4: In Vitro Drug-Drug Interaction Patterns Are Substrate-Dependent Regina W. Wang, Deborah J. Newton, Nini Liu, Drug Metabolism and Disposition	2000	239
Substrate Specificity, Gene Structure, and Tissue-specific Distribution of Multiple Human 3α-Hydroxysteroid Dehydrogenases Marilyn Khanna, Kenan Qin, Regina W. Wang, Journal of Biological Chemistry	1995	175
Cytochrome P450 3A4-Mediated Bioactivation of Raloxifene: Irreversible Enzyme Inhibition and Thiol Adduct Formation Qing Chen, Jason S. Ngui, George A. Doss, Chemical Research in Toxicology GynecologyPharmacotherapyExperimental PharmacologyPharmaceutical ChemistryToxicological Mechanism	2002	156
Roles of Human Hepatic Cytochrome P450s 2C9 and 3A4 in the Metabolic Activation of Diclofenac Wei Tang, Ralph A. Stearns, Regina W. Wang, Chemical Research in Toxicology Metabolic ActivationMetabolomic ProfilingPharmacotherapyToxicological MechanismOxidative Stress	1999	154
Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis. Regina W. Wang, Deborah J. Newton, T D Scheri, PubMed Erythromycin N-demethylationAldo-keto ReductaseChemical BiologyRedox BiologyMolecular Pharmacology	1997	141
Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2) Xiaoyan Chu, John R. Strauss, Michele A. Mariano, Journal of Pharmacology and Experimental Therapeutics	2006	141
CYTOCHROME P450 3A4 IS THE MAJOR ENZYME INVOLVED IN THE METABOLISM OF THE SUBSTANCE P RECEPTOR ANTAGONIST APREPITANT Rosa I. Sánchez, Regina W. Wang, Deborah J. Newton, Drug Metabolism and Disposition	2004	112
Allosteric Behavior in Cytochrome P450-Dependent in Vitro Drug−Drug Interactions: A Prospective Based on Conformational Dynamics William M. Atkins, Regina W. Wang, Anthony Y.H. Lu Chemical Research in Toxicology Conformational DynamicsDrug TargetAltmetric Attention ScorePhysiologically-based Pharmacokinetic ModelingPharmacodynamic Modeling	2001	101
In vitro stimulation of warfarin metabolism by quinidine: increases in the formation of 4'- and 10-hydroxywarfarin. Jason S. Ngui, Qing Chen, Magang Shou, PubMed Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineLiver Physiology	2001	98

Page 1